Forbion raises 1.35bn across two funds
European life sciences venture capital company Forbion has raised two oversubscribed funds totalling 1.35 bn.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1162 entries already.
Entries by Thomas Gabrielczyk
Ariceum Therapeutics extends Series A to 47.75m
/in News/by Thomas GabrielczykGerman radiopharmaceuticals developer Ariceum Therapeutics has raised a further 22.75m extension of its 25m Series A financing announced in June 2022.
Genmab and argenx combine antibody know-how
/in News/by Thomas GabrielczykGenmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialise antibody therapies.
Adaptyv Biosytems launches protein engineering foundry
/in News/by Thomas GabrielczykSwiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools that allow cheap, rapid and minaturised validation of AI-designed proteins.
Researchers activate chemotherapeutics by ultrasound
/in News/by Thomas GabrielczykUltrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies.
FAO presents food safety assessment on cell-based protein products
/in News/by Thomas GabrielczykAt the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins.
Mosaic Therapeutics closes $28m series A financing
/in News/by Thomas GabrielczykWellcome Sanger Institute spin out Mosaic Therapeutics has closed a $28m series A funding led by Syncona Investment Management Ltd, and Cambridge Innovation Capital.
Carbios SAS set to licence and expand PET recycling
/in News/by Thomas GabrielczykFrench enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Insempra and Axxence launch alpha-ionone
/in News/by Thomas GabrielczykPrecision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
German-Chinese ADC collaboration
/in News/by Thomas GabrielczykBioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets.